Ingrid Polakova

7PUBLICATIONS
20CO-AUTHORS
Predictive and prognostic markersGlycoconjugatesTumour immunologyCellular immunologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 14, 2025
Inhibition of Aspartate β-Hydroxylase Enhances Anti-Tumor Immunity.

Shweta Dilip Johari, Katerina Krausova, Barbora Zucha

|May 28, 2024
Multiparametric analysis of the specific immune response against SARS-CoV-2.

Lucie Vránová, Ingrid Poláková, Šárka Vaníková

|Jul 02, 2021
Distinct Responsiveness of Tumor-Associated Macrophages to Immunotherapy of Tumors with Different Mechanisms of Major Histocompatibility Complex Class I Downregulation.

Adrianna Piatakova, Ingrid Polakova, Jana Smahelova

|Apr 30, 2021
CD80 Expression on Tumor Cells Alters Tumor Microenvironment and Efficacy of Cancer Immunotherapy by CTLA-4 Blockade.

Julie Vackova, Ingrid Polakova, Shweta Dilip Johari

|Mar 12, 2020
Abrogation of IFN-γ Signaling May not Worsen Sensitivity to PD-1/PD-L1 Blockade.

Julie Vackova, Adrianna Piatakova, Ingrid Polakova

|Mar 20, 2019
Implementation of Mass Cytometry for Immunoprofiling of Patients with Solid Tumors.

Ingrid Poláková, Ondřej Pelák, Daniel Thürner

Pageof 2

Frequent Collaborators

7 joint publications

Michal Smahel

3 joint publications

Adrianna Piatakova

3 joint publications

Julie Vackova

2 joint publications

Jana Smahelova